USP16 and hepatocellular carcinoma: USP16 also deubiquitinates proteins in oncogenic pathways, for example, IGF2BP3 in gallbladder cancer [48], whereas Ct-HBx inhibits the expression level of USP16 in hepatocellular carcinoma [40], revealing the intrinsic link to cancer development.